Why are guidelines not being followed?;Warum werden leitlinien nicht befolgt?

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 15, 2003, Pages 820-824

  Hoppe, Uta C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOLOGY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; INTERNAL MEDICINE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; ARTICLE; CLINICAL PATHWAY; GERMANY; HUMAN; PUBLIC HEALTH;

CRITICAL PATHWAYS; GERMANY; GUIDELINE ADHERENCE; HUMANS; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES;

EID: 0038300168     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38587     Document Type: Review

References (30)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446
2. Ansari M, Alexander M, Tutar A, Bello D, Massie BM. Cardiology participation improves outcomes in patients with new-onset heart failure in the out-patient setting. J Am Coll Cardiol 2003; 41: 62-68
3. Böger RH. Wie wird die chronische Herzinsuffizienz tatsächlich behandelt? Dtsch Med Wochenschr 2002; 127: 1764-1768
4. Bundesärztekammer, Kassenärztliche, Bundesvereinigung. Beurteilungskriterien für Leitlinien in der medizinischen Versorgung. Dtsch Ärztebl 1997; 94: A2154-2155
5. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. Jama 1999; 282: 1458-1465
6. Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med 1997; 12: 523-30
7. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Grist WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002; 360: 1631-1639
8. Costantini O, Huck K, Carlson MD, Boyd K, Buchter CM, Raiz P, Cooper GS. Impact of a guideline-based disease management team on outcomes of hospitalized patients with congestive heart failure. Arch Intern Med 2001; 161: 177-182
9. Eccles M, McColl E, Steen N, Rousseau N, Grimshaw J, Parkin D, Purves I. Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial. Bmj 2002; 325: 941
10. Faragon JJ, Waite NM, Hobson EH, Seoldo N, VanAmburgh JA, Migden H. Improving aspirin prophylaxis in a primary care diabetic population. Pharmacotherapy 2003; 23: 73-79
11. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. Brit Med J 1998; 317: 858-861
12. Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G, Pfaff H, Hopp HW. Hypertension guidelines and their limitations - the impact of physicians' compliance as evaluated by guideline awareness. J Hypertens 2001; 19: 2079-2086
13. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19: 596-604
14. Hobbs FD, Jones MI, Allan TF, Wilson S, Tobias R. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J 2000; 21: 1877-1887
15. Hoppe UC, Erdmann E im Auftrag der Kommission für Klinische Kardiologie der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 2001; 90: 218-237
16. Hunt HA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Jr. Smith SC. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. Circulation 2001; 104: 2996-3007
17. Kasper EK, Gerstenblith G, Hefter G, Van Anden E, Brinker JA, Thiemann DR, Terrin M, Forman S, Gottlieb SH. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital read-mission. J Am Coll Cardiol 2002; 39: 471-480
18. Khan N, Chockalingam A, Campbell NR. Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol 2002; 18: 657-661
19. Kuo SH. Implementation of asthma guideline in Taiwan - the management in medical centers. J Asthma 2002; 39: 767-770
20. Marciniak TA, Ellerbeck EF, Radford MJ, Kresowik TF, Gold JA, Krumholz HM, Kiefe CI, Allman RM, Vogel RA, Jencks SF. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Med Assoc 1998; 279: 1351-1357
21. Mehta RH, Montoye CK, Gallogly M, Baker P, Blount A, Faul J, Roychoudhury C, Borzak S, Fox S, Franklin M, Freundl M, Kline-Rogers E, LaLonde T, Orza M, Parrish R, Satwicz M, Smith MJ, Sobotka P, Winston S, Riba AA, Eagle KA. Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. J Am Med Assoc 2002; 287: 1269-1276
22. Ollenschläger G, Kirchner H, Fiene M. Leitlinien in der Medizin - scheitern sie an der praktischen Umsetzung? Internist (Berl) 2001; 42: 473-4, 477-483
23. Persson M, Mjorndal T, Carlberg B, Bohlin J, Lindholm LH. Evaluation of a computer-based decision support system for treatment of hypertension with drugs: retrospective, nonintervention testing of cost and guideline adherence. J Intern Med 2000; 247: 87-93
24. Peterson ED. Study shows guideline adherence in hospitals saves lives. Kongressbeitrag American Heart Association Konferenz, 2002
25. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560
26. Rich MW. From clinical trials to clinical practice: bridging the GAP. Jama 2002; 287: 1321-1323
27. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Brit Med J 1996; 312: 71-72
28. Soumerai SB, McLaughlin TJ, Gurwitz JH, Guadagnoli E, Hauptman PJ, Borbas C, Morris N, McLaughlin B, Gao X, Willison DJ, Asinger R, Gobel F. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. J Am Med Assoc 1998; 279: 1358-1363
29. Szucs TD, Schwenkglenks M, Paschen B, Follath F. Cost effectiveness of bisoprolol in treatment of heart failure in Germany. An analysis based on the CI-BIS-II study. Med Klin 2000; 95: 663-71
30. Walsh MN, Jr. Simpson RJ, Wan GJ, Weiss TW, Alexander CM, Markson LE, Berger ML, Pearson TA. Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices. Am J Manag Care 2002; 8: 937-946